raptorjockey - The point of my most recent posts has been to show that there are a multitude of barriers to overcome in order for cytosorb to be used as an adjuvant to CAR T-cell therapy. There certainly appears to be the potential for cytosorb to play a role in this therapy but I think the investors on this board should understand that, at least in the US, there may be a long road ahead for this to occur. I am a long term investor in cytosorb but try to remain realistic in my expectations.